The Full Wiki

More info on CX-516

CX-516: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

CX-516
Systematic (IUPAC) name
6-(piperidin-1-ylcarbonyl)quinoxaline
Identifiers
CAS number 154235-83-3
ATC code  ?
PubChem 148184
Chemical data
Formula C 14H15N3O 
Mol. mass 241.289 g/mol
Synonyms Ampalex, CX-516
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life 45 minutes
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status Investigational New Medicine
Routes  ?

CX-516 is an ampakine compound that works as an AMPA modulator and is being developed by a collaboration of Cortex and Shire and Servier. It was researched as a treatment for Alzheimer's disease, under the brand name Ampalex, and was also being examined as a treatment for ADHD.

CX-516 was the first ampakine compound developed by Cortex and while it showed good in vitro activity and positive results in animal tests, the human trials proved disappointing due mainly to low potency and short half-life. However CX-516 is still widely used in animal research into the ampakine drugs and is the standard reference compound that newer, more potent drugs of this class such as farampator and CX-717 are compared to.

References

See also

Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message